AAAAAA

   
Results: 1-12 |
Results: 12
The Ras-pathway inhibitor, S-trans-trans-farnesylthiosalicylic acid, suppresses experimental allergic encephalomyelitis
Authors: Karussis, D Abramsky, O Grigoriadis, N Chapman, J Mizrachi-Koll, R Niv, H Kloog, Y
Citation: D. Karussis et al., The Ras-pathway inhibitor, S-trans-trans-farnesylthiosalicylic acid, suppresses experimental allergic encephalomyelitis, J NEUROIMM, 120(1-2), 2001, pp. 1-9
Guidelines for autologous blood and marrow stem cell transplantation in multiple sclerosis: a consensus report written on behalf of the European Group for Blood and Marrow Transplantation and the European Charcot Foundation
Authors: Comi, G Kappos, L Clanet, M Ebers, G Fassas, A Fazekas, F Filippi, M Hartung, HP Hertenstein, B Karussis, D Martino, G Tyndall, A van der Meche, FGA
Citation: G. Comi et al., Guidelines for autologous blood and marrow stem cell transplantation in multiple sclerosis: a consensus report written on behalf of the European Group for Blood and Marrow Transplantation and the European Charcot Foundation, J NEUROL, 247(5), 2000, pp. 376-382
Cognitive dysfunction following thalamic stroke: a study of 16 cases and review of the literature
Authors: Karussis, D Leker, RR Abramsky, O
Citation: D. Karussis et al., Cognitive dysfunction following thalamic stroke: a study of 16 cases and review of the literature, J NEUR SCI, 172(1), 2000, pp. 25-29
Linomide induces apoptotic death of cortical CD4/CD8 double positive thymocytes and thymic atrophy by a corticosteroid-independent pathway
Authors: Arbel, I Chezen, E Abramsky, O Karpati, T Ovadia, B Mizrachi-Koll, R Karussis, D
Citation: I. Arbel et al., Linomide induces apoptotic death of cortical CD4/CD8 double positive thymocytes and thymic atrophy by a corticosteroid-independent pathway, CLIN IMMUNO, 90(1), 1999, pp. 108-114
Multiple sclerosis vs Lyme disease: A case presentation to a discussant and a review of the literature
Authors: Karussis, D Weiner, HL Abramsky, O
Citation: D. Karussis et al., Multiple sclerosis vs Lyme disease: A case presentation to a discussant and a review of the literature, MULT SCLER, 5(6), 1999, pp. 395-402
Evidence for the genetic role of human leukocyte antigens in low frequencyDRBI1501 multiple sclerosis patients in Israel
Authors: Karni, A Kohn, Y Safirman, C Abramsky, O Barcellos, L Oksenberg, JR Kahana, E Karussis, D Chapman, J Brautbar, C
Citation: A. Karni et al., Evidence for the genetic role of human leukocyte antigens in low frequencyDRBI1501 multiple sclerosis patients in Israel, MULT SCLER, 5(6), 1999, pp. 410-415
Acute/relapsing experimental autoimmune encephalomyelitis: Induction of long lasting, antigen-specific tolerance by syngeneic bone marrow transplantation
Authors: Karussis, D Vourka-Karussis, U Mizrachi-Koll, R Abramsky, O
Citation: D. Karussis et al., Acute/relapsing experimental autoimmune encephalomyelitis: Induction of long lasting, antigen-specific tolerance by syngeneic bone marrow transplantation, MULT SCLER, 5(1), 1999, pp. 17-21
Linomide downregulates autoimmunity through induction of TH2 cytokine production by lymphocytes
Authors: Karussis, D Abramsky, O Rosenthal, Y Mizrachi-Koll, R Ovadia, H
Citation: D. Karussis et al., Linomide downregulates autoimmunity through induction of TH2 cytokine production by lymphocytes, IMMUNOL LET, 67(3), 1999, pp. 203-208
Evidence of interferon beta-1a dose response in relapsing-remitting MS - The OWIMS study
Authors: Ebers, G Lee, D Rice, G Lesaux, J Kennedy, K Sanders, EACM Versteylen, RJ van Andel, JD Story, JP de Milliano, M O'Connor, P Cheung, G Houston, P Hall, J Comi, G Filippi, M Martinelli, V Santuccio, G Poggi, A Gironi, M Moiola, L Duquette, P Bourgouin, P Pepin, G Poirer, J Bernier, G Dubois, R Metz, L Diamond, RT Bell, R McGowan, D Demchuk, A Harris, E Yeung, M Murphy, A Murray, TJ Vandorpe, R Bhan, V Maxner, C Weldon, P Armstrong, L Bouchard, JP Grondin, P Gosselin, F Thibaut, M Kirouac, L Morin, A Abramsky, O Gomori, JM Karussis, D Karni, A Mor, M Freedman, MS Avruch, L Nelson, R Christie, S Rabinovitch, H Freedman, C Benavente, M Pelletier, J Levrier, O Bensa, P Dalesky, A Paty, D Li, D Rhodes, B Riddehough, A Zhao, G Wang, X Chang, Y Abdul-Ahad, A Ammoury, N Dupont, F Francis, G Furcha, R Galazka, A Hyde, R Olson, M Pernin, MO Shah, S Freedman, M Ebers, G Murray, J O'Connor, P Paty, D Rice, G Francis, G
Citation: G. Ebers et al., Evidence of interferon beta-1a dose response in relapsing-remitting MS - The OWIMS study, NEUROLOGY, 53(4), 1999, pp. 679-686
Is the routine use of intravenous immunoglobulin treatment in neurologic disorders justified? No
Authors: Karussis, D Abramsky, O
Citation: D. Karussis et O. Abramsky, Is the routine use of intravenous immunoglobulin treatment in neurologic disorders justified? No, ARCH NEUROL, 56(8), 1999, pp. 1028-1032
HLA class II susceptibility to multiple sclerosis among Ashkenazi and non-Ashkenazi Jews
Authors: Kwon, OJ Karni, A Israel, S Brautbar, C Amar, A Meiner, Z Abramsky, O Karussis, D
Citation: Oj. Kwon et al., HLA class II susceptibility to multiple sclerosis among Ashkenazi and non-Ashkenazi Jews, ARCH NEUROL, 56(5), 1999, pp. 555-560
Immunosuppressive and immunomodulating therapeutic approaches for induction of self-tolerance in experimental autoimmune encephalomyelitis (EAE and CR-EAE) and multiple sclerosis
Authors: Karussis, D Abramsky, O
Citation: D. Karussis et O. Abramsky, Immunosuppressive and immunomodulating therapeutic approaches for induction of self-tolerance in experimental autoimmune encephalomyelitis (EAE and CR-EAE) and multiple sclerosis, DECADE OF AUTOIMMUNITY, 1999, pp. 179-189
Risultati: 1-12 |